177 Bioengineering of injectable encapsulated aggregates of pluripotent stem cells for therapy of myocardial infarction.
http://www.nature.com/articles/ncomms13306
176 Prevention of atherosclerosis by bioactive palmitoleate through suppression of organelle stress and inflammasome activation.
http://stm.sciencemag.org/content/8/358/358ra126
175 Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome.
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31276-4/fulltext
174 Nestin+ cells direct inflammatory cell migration in atherosclerosis.
http://www.nature.com/articles/ncomms12706
173 Suppression of ischemia in arterial occlusive disease by JNK-promoted native collateral artery development.
https://elifesciences.org/content/5/e18414
172 Atomic force microscopy as a tool to evaluate the risk of cardiovascular diseases in patients.
http://www.nature.com/nnano/journal/v11/n8/abs/nnano.2016.52.html
171 A gene expression survey in patients with coronary artery disease reveals how genetic variation affects the risk of heart failure.
http://science.sciencemag.org/content/353/6301/827
170 Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
http://www.nejm.org/doi/full/10.1056/NEJMoa1603827
169 Association between air pollution and coronary artery calcification within six metropolitan areas in the USA.
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)00378-0/abstract
168 In mice, deficiency in the high-density lipoprotein gene T39 stabilizes liver X receptor (LXR), reducing both atherosclerosis and steatohepatitis, suggesting that T39 inhibition could be an effective strategy for reducing these diseases.
http://www.nature.com/nature/journal/v535/n7611/full/nature18628.html
|
